Neoplasms (Q56828372)

From Wikidata

Jump to navigation Jump to search

article from 2011

Language	Label	Description	Also known as
English	Neoplasms	article from 2011

Statements

scholarly article

0 references

Neoplasms (English)

0 references

publication date

21 March 2011

0 references

118-204

0 references

Skin cancer trends in Northern Ireland and consequences for provision of dermatology services.

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

The changing face of dermatological practice: 25 years' experience

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Dermatological surgery: a comparison of activity and outcomes in primary and secondary care.

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Carcinogenic effects of solar radiation and prevention measures

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Papillomavirus infection and skin cancer in renal allograft recipients

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Environmental pollutants and skin cancer

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Sunscreens, suntans, and skin cancer. Local councils should remove sunbeds from leisure centres

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Non-solar ultraviolet radiation and the risk of basal and squamous cell skin cancer

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Non-melanoma skin cancer and solar keratoses. I. Methods and descriptive results of the South Wales Skin Cancer Study

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Prevalence of solar damage and actinic keratosis in a Merseyside population

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Malignant transformation of solar keratoses to squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Predictors for cutaneous basal- and squamous-cell carcinoma among actinically damaged adults

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Topical treatment of actinic keratoses with 3.0% diclofenac in 2.5% hyaluronan gel.

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Reduction of solar keratoses by regular sunscreen use.

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Salicylic acid ointment peeling of the hands and forearms. Effective nonsurgical removal of pigmented lesions and actinic damage

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

A randomized paired comparison of photodynamic therapy and topical 5-fluorouracil in the treatment of actinic keratoses.

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Weekly pulse dosing: effective and comfortable topical 5-fluorouracil treatment of multiple facial actinic keratoses.

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Does intermittent "pulse" topical 5-fluorouracil therapy allow destruction of actinic keratoses without significant inflammation?

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

A randomized, double-blind, vehicle-controlled study to assess 5% imiquimod cream for the treatment of multiple actinic keratoses

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Dosing with 5% imiquimod cream 3 times per week for the treatment of actinic keratosis: results of two phase 3, randomized, double-blind, parallel-group, vehicle-controlled trials

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Imiquimod 5% cream for the treatment of actinic keratosis: results from a phase III, randomized, double-blind, vehicle-controlled, clinical trial with histology

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Low incidence of new actinic keratoses after topical 5% imiquimod cream treatment: a long-term follow-up study

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Topical 3.0% diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Retinoic acid: Topical treatment of senile or actinic keratoses and basal cell carcinomas

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Multiprofessional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Destructive procedures are the standard of care for treatment of actinic keratoses

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: A prospective, randomized study

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

A comparison of photodynamic therapy using topical methyl aminolevulinate (Metvix) with single cycle cryotherapy in patients with actinic keratosis: a prospective, randomized study

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group.

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trial

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

The carbon dioxide laser. An alternative for the treatment of actinically damaged skin

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

A clinical and histologic evaluation of two medium-depth peels. Glycolic acid versus Jessner's trichloroacetic acid

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Manual resurfacing and trichloroacetic acid for the treatment of patients with widespread actinic damage. Clinical and histologic observations.

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Dermabrasion for prophylaxis and treatment of actinic keratoses

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Dermabrasion of the scalp as a treatment for actinic damage

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Acitretin for prophylaxis of cutaneous malignancies after cardiac transplantation

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Skin cancers after organ transplantation

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Photodynamic therapy does not prevent cutaneous squamous-cell carcinoma in organ-transplant recipients: results of a randomized-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Topical photodynamic therapy in the treatment of actinic keratoses and Bowen's disease in transplant recipients

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Skin cancer: preventive photodynamic therapy in patients with face and scalp cancerization. A randomized placebo-controlled study

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Prevention of non-melanoma skin cancer in organ transplant patients by regular use of a sunscreen: a 24 months, prospective, case-control study

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Multicentre intraindividual randomized trial of topical methyl aminolaevulinate-photodynamic therapy vs. cryotherapy for multiple actinic keratoses on the extremities.

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Photodynamic therapy of actinic keratoses with 8% and 16% methyl aminolaevulinate and home-based daylight exposure: a double-blinded randomized clinical trial.

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Basal cell carcinoma: treatment options and prognosis, a scientific approach to a common malignancy

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

A systematic review of treatment modalities for primary basal cell carcinomas.

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Three-dimensional reconstruction of basal cell carcinomas.

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Prediction of Subclinical Tumor Infiltration in Basal Cell Carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Duplicitous growth of infiltrative basal cell carcinoma: Analysis of clinically undetected tumor extent in a paired case-control study

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Metastatic basal cell carcinoma: report of two cases and literature review

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Basosquamous carcinoma-an under-recognized, high-risk cutaneous neoplasm: case study and review of the literature

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Variations in registration of skin cancer in the United Kingdom

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Skin cancer incidence and the ageing population

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Relationship between sunlight exposure and a key genetic alteration in basal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Trends in the presentation and treatment of basal cell carcinomas

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Basal cell carcinoma of the eyelids and solar ultraviolet radiation exposure

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Risk factors for basal cell carcinoma in a Mediterranean population: role of recreational sun exposure early in life

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Environmental risk factors predisposing to the development of basal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Role of dietary factors in the development of basal cell cancer and squamous cell cancer of the skin.

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Nevoid basal cell carcinoma (Gorlin) syndrome

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Dermoscopic differentiation of a superficial basal cell carcinoma and squamous cell carcinoma in situ

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Exfoliative cytology as a diagnostic test for basal cell carcinoma: a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Perineural spread of cutaneous squamous and basal cell carcinoma: CT and MR detection and its impact on patient management and prognosis

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Orbital invasion by periocular basal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Basal cell carcinoma associated with orbital invasion: clinical features and treatment options

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Aggressive basal cell carcinoma with invasion of the parotid gland, facial nerve, and temporal bone.

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Basal cell carcinoma. Identification and treatment of the high-risk patient

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

A risk scale for predicting extensive subclinical spread of nonmelanoma skin cancer

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Current modalities and new advances in the treatment of basal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Guidelines for the management of basal cell carcinoma. British Association of Dermatologists

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Craniofacial resection for nonmelanoma skin cancer of the head and neck

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Little evidence available on treatments for basal cell carcinoma of the skin

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Use of frozen section analysis in the treatment of basal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Surgical treatment of basal cell carcinomas using standard postoperative histological assessment

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Curative and aesthetic results of surgical treatment of 138 basal-cell carcinomas

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Do basal cell carcinomas recur after complete conventional surgical excision?

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Combined curettage and excision: a treatment method for primary basal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Efficacy of curettage before excision in clearing surgical margins of nonmelanoma skin cancer

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Surgical margins for basal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Efficacy of narrow-margin excision of well-demarcated primary facial basal cell carcinomas

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Accuracy of serial transverse cross-sections in detecting residual basal cell carcinoma at the surgical margins of an elliptical excision specimen

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Incidence of incomplete excision in surgically treated basal cell carcinoma: a retrospective clinical audit

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Audit of histologically incompletely excised basal cell carcinomas: recommendations for management by re-excision

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Incomplete excision of basal cell carcinomas: a retrospective audit

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Surgical management of incompletely excised basal cell carcinomas of the head and neck

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Positive surgical excision margins of a basal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

The significance of incomplete excision in patients with basal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Recurrence rate of positive margin basal cell carcinoma: results of a five-year prospective study

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

A management approach to incompletely excised basal cell carcinomas of skin

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Recurrent basal cell carcinoma after incomplete resection

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

The significance of tumor persistence after incomplete excision of basal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Histological evolution of recurrent basal cell carcinoma and therapeutic implications for incompletely excised lesions

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Chemosurgery for skin cancer: fixed tissue and fresh tissue techniques

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Mohs' micrographic surgery for basal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Five-year results of Mohs' micrographic surgery for aggressive facial basal cell carcinoma in Sweden

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Surgery for basal-cell carcinoma of the face.

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

The Australian Mohs database, part II: periocular basal cell carcinoma outcome at 5-year follow-up.

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Basal cell carcinoma treated with Mohs surgery in Australia II. Outcome at 5-year follow-up.

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Mohs' micrographic surgery for treatment of basal cell carcinoma of the face--results of a retrospective study and review of the literature

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

The incidence of major complications from Mohs micrographic surgery performed in office-based and hospital-based settings

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

A prospective evaluation of the incidence of complications associated with Mohs micrographic surgery

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Tissue repair after Mohs surgery. A plastic surgeon's view

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Mohs micrographic surgery and the otolaryngologist

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Oculoplastic reconstruction following Mohs surgery

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Periocular Mohs micrographic surgery: Results of a dual-site day-surgery service

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Micrographic surgery of malignant skin tumors: a comparison of the frozen technique with paraffin sectioning

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Mohs' surgery of periocular basal cell carcinoma using formalin-fixed sections and delayed closure

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Management of periocular basal cell carcinoma with modified en face frozen section controlled excision

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Peripheral in-continuity tissue examination: a modification of Mohs' micrographic surgery

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Munich method of micrographic surgery for basal cell carcinomas: 5-year recurrence rates with life-table analysis

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Excision of head and neck basal cell carcinoma with a rapid, cross-sectional, frozen-section technique

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Staged operations for basal cell carcinoma of the face

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Small margin excision of periocular basal cell carcinoma: 5 year results

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Small margin (2 mm) excision of peri-ocular basal cell carcinoma with delayed repair

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Mohs micrographic surgery: a cost analysis

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Mohs micrographic surgery vs traditional surgical excision: a cost comparison analysis

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Cost-effectiveness of Mohs Micrographic Surgery vs Surgical Excision for Basal Cell Carcinoma of the Face

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Surgical excision vs Mohs' micrographic surgery for basal-cell carcinoma of the face: randomised controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Mohs' micrographic surgery for basal-cell carcinoma of the face

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Curettage, electrosurgery and skin cancer

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Effectiveness of curettage and electrodesiccation in the removal of basal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Treatment of basal cell carcinoma with curettage alone

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Treatment of basal cell carcinoma by dermatologists in the United Kingdom. British Association of Dermatologists Audit Subcommittee and the British Society for Dermatological Surgery

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Basal cell carcinoma on the lower extremity

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Recurrence Rates of Treated Basal Cell Carcinomas: Part 2: Curettage-Electrodesiccation

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Curettage and electrodesiccation in the treatment of midfacial basal cell epithelioma

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Failure of curettage and electrodesiccation for removal of basal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Does inflammation contribute to the eradication of basal cell carcinoma following curettage and electrodesiccation?

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Does wound healing contribute to the eradication of basal cell carcinoma following curettage and electrodessication?

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

An open-label, pilot study examining the efficacy of curettage followed by imiquimod 5% cream for the treatment of primary nodular basal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

A follow-up study of recurrence and cosmesis in completely responding superficial and nodular basal cell carcinomas treated with methyl 5-aminolaevulinate-based photodynamic therapy alone and with prior curettage

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Five-year results of curettage-cryosurgery for 100 consecutive auricular non-melanoma skin cancers

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Statistical data on malignant tumors in cryosurgery: 1982.

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Cryosurgery of cutaneous carcinomas. An 18-year study of 3,022 patients with 4,228 carcinomas

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Cryosurgery in the treatment of basal cell carcinoma. Assessment of one and two freeze-thaw cycle schedules

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Fractional cryosurgery. A new technique for basal cell carcinoma of the eyelids and periorbital area

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Cryotherapy for skin cancer: results over a 5-year period using liquid nitrogen spray cryosurgery

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Histologic cure of basal cell carcinoma treated with cryosurgery

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Cryosurgery for skin cancer: 30-year experience and cure rates

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Cryosurgery in difficult to treat basal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Recurrent basal cell carcinoma treated with cryosurgery

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

A reappraisal of cryosurgery for eyelid basal cell carcinomas

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Cryotherapy for eyelid and periocular basal cell carcinomas: outcome in 166 cases over an 8-year period

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Cryosurgery of eyelid basal cell carcinomas

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Photodynamic therapy vs. cryosurgery of basal cell carcinomas: results of a phase III clinical trial

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Cosmetic results of cryosurgery versus surgical excision for primary uncomplicated basal cell carcinomas of the head and neck

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Ultrapulse CO2 used for the successful treatment of basal cell carcinomas found in patients with basal cell nevus syndrome

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

The use of Toll-like receptor-7 agonist in the treatment of basal cell carcinoma: an overview

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: results of a multicenter 6-week dose-response trial

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: a double-blind, randomized, vehicle-controlled study

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from a randomized vehicle-controlled phase III study in Europe

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Efficacy of topical 5% imiquimod cream for the treatment of nodular basal cell carcinoma: comparison of dosing regimens

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

A phase III, randomized, open label study to evaluate the safety and efficacy of imiquimod 5% cream applied thrice weekly for 8 and 12 weeks in the treatment of low-risk nodular basal cell carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Fifty-five basal cell carcinomas treated with topical imiquimod: outcome at 5-year follow-up

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Imiquimod 5% cream for the treatment of superficial and nodular basal cell carcinoma: randomized studies comparing low-frequency dosing with and without occlusion

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

The use of imiquimod 5% cream for the treatment of superficial basal cell carcinomas in a basal cell nevus syndrome patient

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Topical imiquimod treatment of superficial and nodular basal cell carcinomas in patients affected by basal cell nevus syndrome: a preliminary report

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Photodynamic therapy and imiquimod immunotherapy for basal cell carcinomas

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Bowen's disease, solar keratoses and superficial basal cell carcinomas treated by photodynamic therapy using a large-field incoherent light source

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Topical 5-aminolaevulinic acid photodynamic therapy for cutaneous lesions: outcome and comparison of light sources.

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005.

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma: results of a multicenter randomized prospective trial

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Five-year follow-up of a randomized, prospective trial of topical methyl aminolevulinate photodynamic therapy vs surgery for nodular basal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Topical methyl aminolaevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional treatment.

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Photodynamic therapy with topical methyl aminolaevulinate for 'difficult-to-treat' basal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Treatment of diffuse basal cell carcinomas and basaloid follicular hamartomas in nevoid basal cell carcinoma syndrome by wide-area 5-aminolevulinic acid photodynamic therapy

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

delta-Aminolevulinic acid and blue light photodynamic therapy for treatment of multiple basal cell carcinomas in two patients with nevoid basal cell carcinoma syndrome

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Radiotherapy alone for clinical T4 skin carcinoma of the head and neck with surgery reserved for salvage

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Interstitial brachytherapy of periorificial skin carcinomas of the face: a retrospective study of 97 cases

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Treatment of skin carcinomas of the face by high-dose-rate brachytherapy and custom-made surface molds

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Radiotherapy for locally advanced basal cell and squamous cell carcinomas of the skin

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Basal cell carcinoma of the lip treated with radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Results of radiotherapy for epithelial skin cancer of the pinna: the Princess Margaret Hospital experience, 1982-1993.

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2.

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Radiotherapy of skin carcinomas of the pinna: a study of 115 lesions in 108 patients

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Basal cell carcinoma of the face: surgery or radiotherapy? Results of a randomized study

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Treatment of basal-cell carcinoma: comparison of radiotherapy and cryotherapy

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Evaluation of cosmetic results of a randomized trial comparing surgery and radiotherapy in the treatment of basal cell carcinoma of the face

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Possibility of treating basal cell carcinomas of nevoid basal cell carcinoma syndrome with superficial x-ray therapy

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

High incidence of second basal cell skin cancers

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Prognostic factors for a subsequent basal cell carcinoma: implications for follow-up.

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Truncal tumor site is associated with high risk of multiple basal cell carcinoma and is influenced by glutathione S-transferase, GSTT1, and cytochrome P450, CYP1A1 genotypes, and their interaction.

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Cutaneous basal cell carcinomas: distinct host factors are associated with the development of tumors on the trunk and on the head and neck

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Follow-up of basal cell carcinomas: an audit of current practice

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Basal cell carcinoma follow-up practices by dermatologists: a national survey.

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Guidelines for the management of basal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Topical imiquimod or fluorouracil therapy for basal and squamous cell carcinoma: a systematic review

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Genetics and risk factors for basal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Interventions for basal cell carcinoma of the skin: systematic review

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Guidelines for management of Bowen's disease. British Association of Dermatologists

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Thirteen-year retrospective study of Bowen's disease in Northern Ireland

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Body site distribution of Bowen's disease.

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Summary of inaugural meeting of the Skin Care in Organ Recipients Group, UK, held at the Royal Society of Medicine, 7 October 2004.

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Skin cancers in renal-transplant recipients occur more frequently than previously recognized in a temperate climate

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Human papillomavirus and extragenital in situ carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Human papillomavirus infection in actinic keratosis and bowen’s disease: comparative study with expression of cell-cycle regulatory proteins p21waf1/cip1, p53, pcna, ki-67, and bcl-2 in positive and negative lesions

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Bowen's disease (squamous cell carcinoma in situ) in Kauai, Hawaii. A population-based incidence report

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Perianal Bowen's disease

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Perianal Bowen's disease: associated tumors, human papillomavirus, surgery, and other controversies

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Perianal Bowen's disease: a clinicopathologic study of 47 patients

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Treatment of cutaneous Bowen's disease with particular emphasis on the problem of lower leg lesions.

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Erbium:YAG laser pretreatment accelerates the response of Bowen's disease treated by topical 5-fluorouracil

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Randomized comparison of photodynamic therapy with topical 5-fluorouracil in Bowen's disease

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Topical treatment of Bowen's disease with 5-Fluorouracil

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Imiquimod 5% cream in the treatment of Bowen's disease

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Treatment of Bowen's disease using a cycle regimen of imiquimod 5% cream

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Treatment of large facial Bowen's disease: case report

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Treatment of Bowen's disease and erythroplasia of Queyrat

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Treatment of Bowen's disease with imiquimod 5% cream in transplant recipients

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Bowen's disease (squamous cell carcinoma in situ) in immunosuppressed patients treated with imiquimod 5% cream and a cox inhibitor, sulindac: potential applications for this combination of immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Squamous cell carcinoma in situ (Bowen's disease) in renal transplant patients treated with 5% imiquimod and 5% 5-fluorouracil therapy

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Comparison of cryotherapy with curettage in the treatment of Bowen's disease: a prospective study.

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Respective roles of radiotherapy and surgery in the management of epidermoid carcinoma of the anal margin. Series of 57 patients

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Cutaneous squamous carcinoma in situ (Bowen's disease): treatment with Mohs micrographic surgery.

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Photodynamic therapy of multiple nonmelanoma skin cancers with verteporfin and red light-emitting diodes: two-year results evaluating tumor response and cosmetic outcomes

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Photodynamic therapy for Bowen's disease (squamous cell carcinoma in situ) of the digit

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or Fluorouracil for treatment of squamous cell carcinoma in situ: Results of a multicenter randomized trial.

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Photodynamic therapy with violet light and topical 6-aminolaevulinic acid in the treatment of actinic keratosis, Bowen's disease and basal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Radiation therapy for Bowen's disease: lessons for lesions of the lower extremity

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Treatment of Bowen's disease with a specially designed radioactive skin patch

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Treatment of Bowen's disease of the digit with carbon dioxide laser

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Bowen's disease of the distal digit. Outcome of treatment with carbon dioxide laser vaporization

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Treating Bowen's disease: a cost-minimization study

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Guidelines for management of Bowen's disease: 2006 update

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

The many faces of squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Trends in the population-based incidence of squamous cell carcinoma of the skin first diagnosed between 1984 and 1992.

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Changing trends in non-melanoma skin cancer in South Wales, 1988-98.

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Use of tanning devices and risk of basal cell and squamous cell skin cancers

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Arsenic in Dermatology

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

A population-based study of skin cancer incidence and prevalence in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Squamous cutaneous epithelial cell carcinoma in two CML patients with progressive disease under imatinib treatment

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Rapid onset of cutaneous squamous cell carcinoma in patients with rheumatoid arthritis after starting tumor necrosis factor alpha receptor IgG1-Fc fusion complex therapy

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

High recurrence rates of squamous cell carcinoma after Mohs' surgery in patients with chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Detection of new human papillomavirus sequences in skin lesions of a renal transplant recipient and characterization of one complete genome related to epidermodysplasia verruciformis-associated types.

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Human papillomavirus and the development of non-melanoma skin cancer

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals.

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Skin cancer in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Skin cancer in Australian heart transplant recipients

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Aggressive Biologic Behavior of Basal- and Squamous-Cell Cancers in Patients with Chronic Lymphocytic Leukemia or Chronic Lymphocytic Lymphoma

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Prolonged prevention of squamous cell carcinoma of the skin by regular sunscreen use.

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

High sun protection factor sunscreens in the suppression of actinic neoplasia

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Immunosuppressants and skin cancer in transplant patients: focus on rapamycin

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Oral retinoids for the prevention of skin cancers in solid organ transplant recipients: a systematic review of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Oral retinoid use reduces cutaneous squamous cell carcinoma risk in patients with psoriasis treated with psoralen-UVA: a nested cohort study

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Safety and efficacy of 5% imiquimod cream for the treatment of skin dysplasia in high-risk renal transplant recipients: randomized, double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Microstaging of squamous cell carcinomas

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Risk factors related to locoregional recurrence in squamous cell carcinoma of the skin.

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Biology of cutaneous squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Recurrent squamous cell carcinoma of the skin

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Histologic subtyping and malignancy assessment of cutaneous squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Principles of management of basal and squamous cell carcinoma of the skin

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Organ specificity of tumor metastasis: role of preferential adhesion, invasion and growth of malignant cells at specific secondary sites

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Adjuvant radiotherapy after excision of cutaneous squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Lymph node staging in patients with clinically negative neck examinations by ultrasound and ultrasound-guided aspiration cytology

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Ultrasonography-guided fine-needle aspiration for the assessment of cervical metastases

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Lymphatic mapping and sentinel lymphadenectomy for 106 head and neck lesions: contrasts between oral cavity and cutaneous malignancy

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Sentinel node biopsy for high-risk nonmelanoma cutaneous malignancy.

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Lymphatic mapping and sentinel lymph node biopsy in squamous cell carcinoma of the lower lip.

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Sentinel lymph node biopsy identifies occult nodal metastases in patients with Marjolin's ulcer.

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

The use of sentinel lymph node biopsy in squamous cell carcinoma of the foot: a case report.

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

THE TREATMENT OF SKIN CANCER. A STATISTICAL STUDY OF 1,341 SKIN TUMORS COMPARING RESULTS OBTAINED WITH IRRADIATION, SURGERY, AND CURETTAGE FOLLOWED BY ELECTRODESICCATION.

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Occurrence of cutaneous basal cell and squamous cell malignancies among those with a prior history of skin cancer. The Skin Cancer Prevention Study Group

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Radiotherapy management for squamous cell carcinoma of the nasal skin: the Princess Margaret Hospital experience

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Radiotherapy for epithelial skin cancer

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Soft x-ray therapy for cutaneous basal cell and squamous cell carcinomas

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Infiltrative squamous cell carcinoma on the scalp after treatment with 5% imiquimod cream.

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Successful treatment of invasive squamous cell carcinoma using topical imiquimod

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Imiquimod: an effective alternative for the treatment of invasive cutaneous squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Intralesional interferon alpha-2b in the treatment of basal cell carcinoma and squamous cell carcinoma: revisited

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Treatment of squamous cell carcinoma with intralesional 5-Fluorouracil

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

A review of laser and photodynamic therapy for the treatment of nonmelanoma skin cancer

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Squamous cell carcinoma of the eyelid treated with photodynamic therapy

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Sunburn and melanoma: how strong is the evidence?

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Melanoma and sunburn.

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Epidemiology of Malignant Melanoma: Intermittent or Total Accumulated Exposure to the Sun?

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

High Prevalence of Vitamin D Inadequacy and Implications for Health

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Serum 25-hydroxyvitamin D3 levels are associated with breslow thickness at presentation and survival from melanoma

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Vitamin D receptor gene polymorphisms, serum 25-hydroxyvitamin D levels, and melanoma: UK case-control comparisons and a meta-analysis of published VDR data

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Early diagnosis of cutaneous melanoma: revisiting the ABCD criteria

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Cancer Research Campaign health education programme to promote the early detection of cutaneous malignant melanoma. I. Work-load and referral patterns

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Early detection of cutaneous malignant melanoma in Britain

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Cutaneous malignant melanoma in Scotland: incidence, survival, and mortality, 1979-94. The Scottish Melanoma Group

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Changing incidence and mortality from cutaneous malignant melanoma

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Risk factors for cutaneous melanoma. A practical method of recognizing predisposed individuals

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Risk of cutaneous melanoma in relation to the numbers, types and sites of naevi: a case-control study

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Melanomas in renal transplant recipients: the London experience, and invitation to participate in a European study

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Large congenital melanocytic nevi and the risk for the development of malignant melanoma. A prospective study.

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Congenital nevi less than or equal to 10 cm as precursors to melanoma. 52 cases, a review, and a new conception

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

High-risk Melanoma Susceptibility Genes and Pancreatic Cancer, Neural System Tumors, and Uveal Melanoma across GenoMEL

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Selection criteria for genetic assessment of patients with familial melanoma

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Effect of initial biopsy procedure on prognosis in Stage 1 invasive cutaneous malignant melanoma: review of 1086 patients

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Influence of biopsy on the prognosis of cutaneous melanoma of the head and neck

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Interobserver reproducibility of ulceration assessment in primary cutaneous melanomas.

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

The correlation of regression in primary melanoma with sentinel lymph node status.

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Pathology of sentinel lymph nodes for melanoma

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

The microanatomic location of metastatic melanoma in sentinel lymph nodes predicts nonsentinel lymph node involvement.

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Role of radiologic imaging at the time of initial diagnosis of stage T1b-T3b melanoma.

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

F-18 fluorodeoxy-D-glucose positron emission tomography scan in the initial evaluation of patients with a primary melanoma thicker than 4 mm.

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Futility of fluorodeoxyglucose F 18 positron emission tomography in initial evaluation of patients with T2 to T4 melanoma

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Ultrasound-guided fine needle aspiration cytology prior to sentinel lymph node biopsy in melanoma patients.

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Routine use of FDG-PET scans in melanoma patients with positive sentinel node biopsy.

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Routine positron emission tomography and positron emission tomography/computed tomography in melanoma staging with positive sentinel node biopsy is of limited benefit

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Thin stage I primary cutaneous malignant melanoma. Comparison of excision with margins of 1 or 3 cm.

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Efficacy of 2-cm surgical margins for intermediate-thickness melanomas (1 to 4 mm). Results of a multi-institutional randomized surgical trial

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Excision margins in high-risk malignant melanoma

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Narrow excision (1-cm margin). A safe procedure for thin cutaneous melanoma

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Excision margins for primary cutaneous melanoma: updated pooled analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Survey of U.K. current practice in the treatment of lentigo maligna.

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Treatment of Lentigo Maligna and Lentigo Maligna Melanoma

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Imiquimod in the treatment of lentigo maligna

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Staged excision versus Mohs micrographic surgery for lentigo maligna and lentigo maligna melanoma

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Sentinel-node biopsy or nodal observation in melanoma

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Importance of sentinel lymph node biopsy in patients with thin melanoma

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Patterns of recurrence in patients with melanoma after radical lymph node dissection

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Groin dissection in malignant melanoma

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Surgical management of the groin lymph nodes in melanoma in the era of sentinel lymph node dissection.

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Positive deep nodes in the groin and survival in malignant melanoma

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Positive iliac and obturator nodes in melanoma: survival and prognostic factors

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Experience with 998 cutaneous melanomas of the head and neck over 30 years

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Use of the carbon dioxide laser to manage cutaneous metastases from malignant melanoma

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Isolated limb infusion for in-transit malignant melanoma of the extremity: a well-tolerated but less effective alternative to hyperthermic isolated limb perfusion

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Improved survival for stage IV melanoma from an unknown primary site

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

A randomized trial of surgery in the treatment of single metastases to the brain.

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Surgical excision for single cerebral metastasis?

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Chemotherapy compared with biochemotherapy for the treatment of metastatic melanoma: a meta-analysis of 18 trials involving 2,621 patients

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Durable complete responses with high-dose bolus interleukin-2 in patients with metastatic melanoma who have experienced progression after biochemotherapy

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Surgical management of cerebral metastases from melanoma: outcome in 147 patients treated at a single institution over two decades

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Stereotactic radiosurgery for cerebral metastatic melanoma: factors affecting local disease control and survival.

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Stereotactic radiosurgical treatment in 103 patients for 153 cerebral melanoma metastases.

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Effect of pregnancy on survival in women with cutaneous malignant melanoma.

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Malignant melanoma in pregnancy. A population-based evaluation

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Cutaneous malignant melanoma in women. Phenotypic characteristics, sun exposure, and hormonal factors: a case-control study from Italy.

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

A pooled analysis of 10 case-control studies of melanoma and oral contraceptive use

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Hormone replacement therapy after surgery for stage 1 or 2 cutaneous melanoma

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Levodopa therapy and the risk of malignant melanoma

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Follow-up in patients with localised primary cutaneous melanoma

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Primary staging and follow-up in melanoma patients--monocenter evaluation of methods, costs and patient survival

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanoma

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

An evidence base for reconsidering current follow-up guidelines for patients with cutaneous melanoma less than 0.5 mm thick at diagnosis

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

U.K. guidelines for the management of cutaneous melanoma

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Excision margins in the treatment of primary cutaneous melanoma: a systematic review of randomized controlled trials comparing narrow vs wide excision

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Sentinel node biopsy has no benefit for patients whose primary cutaneous melanoma has metastasized to a lymph node and therefore should be abandoned now.

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Skin cancer prevention and UV-protection: how to avoid vitamin D-deficiency?

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Skin cancer prevention in Australia

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Treatments for metastatic melanoma: synthesis of evidence from randomized trials

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Melanoma--Part 1: epidemiology, risk factors, and prevention

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Melanoma--part 2: management

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Prognosis in cutaneous T-cell lymphoma by skin stage: long-term survival in 489 patients

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Clinical stage IA (limited patch and plaque) mycosis fungoides. A long-term outcome analysis.

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Clinical characteristics and long-term outcome of patients with generalized patch and/or plaque (T2) mycosis fungoides.

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Prognostic factors in erythrodermic mycosis fungoides and the Sézary syndrome

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Topical corticosteroids for mycosis fungoides. Experience in 79 patients

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Phase 1 and 2 trial of bexarotene gel for skin-directed treatment of patients with cutaneous T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

A phase III, randomized, double-blind, placebo-controlled study of peldesine (BCX-34) cream as topical therapy for cutaneous T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Treatment of mycosis fungoides with photochemotherapy (PUVA): long-term follow-up

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Photochemotherapy alone or combined with interferon alpha-2a in the treatment of cutaneous T-cell lymphoma.

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Narrowband TL-01 phototherapy for patch-stage mycosis fungoides.

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

The role of recombinant interferon alfa-2a in the therapy of cutaneous T-cell lymphomas

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Phase II study of recombinant human interferon gamma for treatment of cutaneous T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Systemic therapy of cutaneous T-cell lymphomas (mycosis fungoides and the Sézary syndrome).

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Low-dose methotrexate to treat erythrodermic cutaneous T-cell lymphoma: results in twenty-nine patients

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Pegylated doxorubicin for primary cutaneous T-cell lymphoma: a report on ten patients with follow-up

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

T-cell depletion and autologous stem cell transplantation in the management of tumour stage mycosis fungoides with peripheral blood involvement

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Remission of refractory Sezary syndrome after bone marrow transplantation from a matched unrelated donor

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Phase 2 study of alemtuzumab (anti-CD52 monoclonal antibody) in patients with advanced mycosis fungoides/Sezary syndrome

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Extracorporeal photopheresis in Sézary syndrome. No significant effect in the survival of 44 patients with a peripheral blood T-cell clone.

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Extracorporeal photopheresis in cutaneous T-cell lymphoma. Inconsistent data underline the need for randomized studies

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Joint British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous T-cell lymphomas.

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

The new World Health Organization classification of haematopoietic and lymphoid tumours: a dermatopathological perspective

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

How I treat mycosis fungoides and Sézary syndrome

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Bexarotene therapy for mycosis fungoides and Sézary syndrome.

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

U.K. consensus statement on the use of extracorporeal photopheresis for treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome.

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

A Randomized Controlled Trial to Assess Sunscreen Application and Beta Carotene Supplementation in the Prevention of Solar Keratoses

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Detection of a Peripheral Blood T Cell Clone is an Independent Prognostic Marker in Mycosis Fungoides

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Sunburn and p53 in the onset of skin cancer

1 reference

https://api.crossref.org/works/10.1002%2F9781444329865.CH3

21 January 2018

Identifiers

10.1002/9781444329865.CH3

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q56828372&oldid=2009366691"